MARKET

CLPT

CLPT

ClearPoint Neuro Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.370
+0.130
+4.01%
Closed 16:00 07/10 EDT
OPEN
3.300
PREV CLOSE
3.240
HIGH
3.435
LOW
3.300
VOLUME
5.09K
TURNOVER
--
52 WEEK HIGH
6.33
52 WEEK LOW
2.860
MARKET CAP
52.26M
P/E (TTM)
-8.0295
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CLPT stock price target is 13.00 with a high estimate of 13.00 and a low estimate of 13.00.

EPS

CLPT News

More
64 Biggest Movers From Yesterday
Gainers
Benzinga · 05/22 09:26
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12)
Benzinga · 05/13 11:40
ClearPoint Neuro Reports First Quarter 2020 Results
GlobeNewswire · 05/12 21:05
ClearPoint Neuro Q1 EPS $(0.130) Down From $(0.110) YoY, Sales $3.116M Up From $2.473M YoY
ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.130) per share. This is a 18.18 percent decrease over losses of $(0.110) per share from the same period last year. The company reported $3.116 million in
Benzinga · 05/12 20:11
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) gained about 6% for the week.
Benzinga · 05/10 19:40
ClearPoint Neuro to Announce First Quarter 2020 Results on May 12
GlobeNewswire · 05/07 13:00
Biotechnology Leader and Surgeon Dr. Matthew Klein Joins ClearPoint Neuro Board of Directors
GlobeNewswire · 04/17 12:10
ClearPoint Neuro sees 24% jump in Q1 revenue
seekingalpha · 04/16 20:09

Industry

Advanced Medical Equipment & Technology
-0.60%
Healthcare Equipment & Supplies
-0.31%

Hot Stocks

Symbol
Price
%Change

About CLPT

Clearpoint Neuro Inc, formerly MRI Interventions, Inc., MRI Interventions, Inc. is a medical device company. The Company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. It has two product platforms: ClearPoint system, which is used to perform minimally invasive surgical procedures in the brain and ClearTrace system, which is under development, to be used to perform minimally invasive surgical procedures in the heart. Its ClearPoint system is a neuro-navigation system designed for placing catheters and electrodes to treat a range of neurological diseases and conditions and for performing biopsies. Its ClearTrace system is designed to deliver catheter-based therapies to treat certain cardiac diseases. Both systems utilize intra-procedural MRI to guide the procedures.
More

Webull offers kinds of Clearpoint Neuro Inc stock information, including NASDAQ:CLPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLPT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CLPT stock methods without spending real money on the virtual paper trading platform.